Trustees Of Columbia University In The City Of New York Xilio Therapeutics, Inc. Transaction History
Trustees Of Columbia University In The City Of New York
- $46.9 Million
- Q4 2023
A detailed history of Trustees Of Columbia University In The City Of New York transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Trustees Of Columbia University In The City Of New York holds 249,635 shares of XLO stock, worth $237,153. This represents 0.29% of its overall portfolio holdings.
Number of Shares
249,635
Previous 249,635
-0.0%
Holding current value
$237,153
Previous $526,000
73.95%
% of portfolio
0.29%
Previous 1.04%
Shares
1 transactions
Others Institutions Holding XLO
# of Institutions
32Shares Held
10MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA2.81MShares$2.67 Million0.46% of portfolio
-
River Vest Venture Management LLC St. Louis, MO1.44MShares$1.37 Million19.12% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD1.44MShares$1.37 Million0.04% of portfolio
-
Atlas Venture Life Science Advisors, LLC993KShares$943,2660.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA903KShares$857,4040.0% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $26.1M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...